SEC Tracker
Get the app

Autolus Therapeutics AUTL

Autolus Therapeutics announces Q3 2026 results

Autolus Therapeutics (AUTL) filed an 8-K with the SEC on Nov 10, 2026, 7:25 am ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Revenue of $4.1M for Q3 2026

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Autolus Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.